Bureau Central Du Recensement company information, Employees & Contact Information

BCR-ABL: The molecular mastermind behind chronic myeloid leukemia ScienceDirect.com

Temporal changes of tibial eminence after bi-cruciate retaining total knee arthroplasty BMC Musculoskeletal Disorders

Timing and trajectory of BCR::ABL1- driven chronic myeloid leukaemia Nature

Association between femorotibial rotational mismatch and early clinical outcomes after bi-cruciate retaining total knee arthroplasty BMC Musculoskeletal Disorders

BCR-UNet: Bi-directional ConvLSTM residual U-Net for retinal blood vessel segmentation Frontiers

Biopharmaceutical Chief Executive Officers (CEO) Roundtable IFPMA

Systems‐wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation EMBO Press

Bi-caudate ratio as a MRI marker of white matter atrophy in multiple sclerosis and ischemic leukocencephalopathy SpringerOpen

Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells ScienceDirect.com

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells Frontiers

The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib | Leukemia Nature

Short-term clinical results of bicruciate-retaining total knee arthroplasty using personalized alignment BMC Musculoskeletal Disorders

Advances in antibody discovery from human BCR repertoires Frontiers

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy - Leukemia Nature

A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia Cell Communication and Signaling

BCR selection and affinity maturation in Peyer’s patch germinal centres Nature

The IgM receptor FcμR limits tonic BCR signaling by regulating expression of the IgM BCR Nature

Association between pre- and postoperative rotational mismatches of the femorotibial components and bones in bi-cruciate retaining and posterior stabilized total knee arthroplasty Nature

Tuning BCR signalling at lipid rafts Nature

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy Nature

Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy Journal of Hematology & Oncology

Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells Nature

Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to pneumococcal vaccination | Communications Biology Nature

BCR Affinity Influences T-B Interactions and B Cell Development in Secondary Lymphoid Organs Frontiers

A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review BMC Cancer

Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation Nature

Declaration of Bcr-Abl1 independence Nature

Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices Taylor & Francis Online

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia Nature

Editorial: BCR Signaling and B Cell Activation Frontiers

Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing Cancer Cell International

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination Frontiers

B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage Nature

Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance Nature

Galectin-9 binds IgM-BCR to regulate B cell signaling Nature

scTCR/BCR Workshop in Berlin: Single Cell Methods for B and T Cell Receptor Repertoire Dynamics Berlin Institute of Health

STING couples with PI3K to regulate actin reorganization during BCR activation Science | AAAS

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia BMC Cancer

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper Journal of Hematology & Oncology

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia Frontiers

Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development Nature

Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1 ACS Publications

The Role of the Pre-B Cell Receptor in B Cell Development, Repertoire Selection, and Tolerance Frontiers

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation Nature

New insights into pre-BCR and BCR signalling with relevance to B cell malignancies Nature

Reactivation of IgG-switched memory B cells by BCR-intrinsic signal amplification promotes IgG antibody production Nature

Design of substrate-based BCR-ABL kinase inhibitors using the cyclotide scaffold Nature

A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI The Lancet

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors Nature

Binding Corporate Rules (BCR): the CNIL publishes a monitoring tool CNIL

Allosteric inhibitors of Bcr-abl–dependent cell proliferation Nature

Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia Nature

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia The New England Journal of Medicine

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis Nature

BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations Nature

How Do I Opt-in for BCR? Department of Agriculture, Environment and Rural Affairs

BACHELOR OF COMMUNITY REHABILITATION Cumming School of Medicine